Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Tim Flaadt"'
Autor:
Thomas Eichholz, Michaela Döring, Stefano Giardino, Bernd Gruhn, Christian Seitz, Tim Flaadt, Wolfgang Schwinger, Martin Ebinger, Ursula Holzer, Markus Mezger, Heiko-Manuel Teltschik, Monika Sparber-Sauer, Ewa Koscielniak, Michael Abele, Rupert Handgretinger, Peter Lang
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundPrognosis of children with primary disseminated or metastatic relapsed sarcomas remains dismal despite intensification of conventional therapies including high-dose chemotherapy. Since haploidentical hematopoietic stem cell transplantation
Externí odkaz:
https://doaj.org/article/ffe18b246e0349b6adb01290d8fb11c8
Autor:
Christian Martin Seitz, Tim Flaadt, Markus Mezger, Anne-Marie Lang, Sebastian Michaelis, Marie Katz, Desireé Syring, Alexander Joechner, Armin Rabsteyn, Nikolai Siebert, Sascha Troschke-Meurer, Maxi Zumpe, Holger N. Lode, Sile F. Yang, Daniel Atar, Anna-Sophia Mast, Sophia Scheuermann, Florian Heubach, Rupert Handgretinger, Peter Lang, Patrick Schlegel
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Haploidentical stem cell transplantation (haplo SCT) in Stage IV neuroblastoma relapsed patients has been proven efficacious, while immunotherapy utilizing the anti-GD2 antibody dinutuximab beta has become a standard treatment for neuroblastoma. The
Externí odkaz:
https://doaj.org/article/3db6c45432c649c5ab96cdd2344832c5
Autor:
Ann-Cathrine Berking, Tim Flaadt, Yvonne Lisa Behrens, Ayami Yoshimi, Alfred Leipold, Ursula Holzer, Peter Lang, Leticia Quintanilla-Martinez, Brigitte Schlegelberger, Andreas Reiter, Charlotte Niemeyer, Brigitte Strahm, Gudrun Göhring
Publikováno v:
Cancer Genetics. :29-34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be2c7ab247f588bed7041a31bf5a2e90
https://doi.org/10.1016/j.cancergen.2023.01.002
https://doi.org/10.1016/j.cancergen.2023.01.002
Autor:
Tim Flaadt, Ruth L. Ladenstein, Martin Ebinger, Holger N. Lode, Helga Björk Arnardóttir, Ulrike Poetschger, Wolfgang Schwinger, Roland Meisel, Friedhelm R. Schuster, Michaela Döring, Peter F. Ambros, Manon Queudeville, Jörg Fuchs, Steven W. Warmann, Jürgen Schäfer, Christian Seitz, Patrick Schlegel, Ines B. Brecht, Ursula Holzer, Tobias Feuchtinger, Thorsten Simon, Johannes H. Schulte, Angelika Eggert, Heiko-Manuel Teltschik, Toni Illhardt, Rupert Handgretinger, Peter Lang
Publikováno v:
Journal of Clinical Oncology.
PURPOSE Patients with relapsed high-risk neuroblastoma (rHR-NB) have a poor prognosis. We hypothesized that graft-versus-neuroblastoma effects could be elicited by transplantation of haploidentical stem cells (haplo-SCT) exploiting cytotoxic function
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26b7baed3c7a0251bab53e239c2504b8
https://doi.org/10.1200/jco.22.01630
https://doi.org/10.1200/jco.22.01630
Autor:
Lauriane Lemelle, Tim Flaadt, Brice Fresneau, Antoine Moya-Plana, Beate Timmermann, Jelena Roganovic, Andrea Ferrari, Giulia Fichera, Ulrich M. Lauer, Tal Ben-Ami, Dominik T. Schneider, Christian Vokuhl, Stephanie Bolle, Elisabeth Fox, Steven G. DuBois, Carlos Rodriguez-Galindo, Gianni Bisogno, Aurore Surun, Ines B. Brecht, Daniel Orbach
Nuclear protein of the testis (NUT) carcinoma (NC) is a rare and highly aggressive tumor mainly occurring in adolescents and young adults, defined by the presence of a somatic NUTM1 rearrangement. The aim is to establish internationally harmonized co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21f739d4dfe4a6980eab6f5b275a32d0
https://www.ncbi.nlm.nih.gov/pubmed/36219702
https://www.ncbi.nlm.nih.gov/pubmed/36219702
Autor:
Peter Lang, Ilias Tsiflikas, Sebastian Gassenmaier, Marcel Barreuther, Tim Flaadt, Roland Bares, Juergen F. Schaefer
Publikováno v:
Pediatric Radiology. 51:1223-1230
The prognostic value of the International Society of Paediatric Oncology European Neuroblastoma Research Network (SIOPEN) skeletal score using 123iodine-metaiodobenzylguanidine (MIBG) has been confirmed for people with high-risk neuroblastoma. Whole-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3dfe7dd7fa19740024eedf45f7ce6ee7
https://doi.org/10.1007/s00247-020-04960-2
https://doi.org/10.1007/s00247-020-04960-2
Autor:
Karin Melanie Cabanillas Stanchi, Manon Queudeville, Veronika Klaus, Nora Rieflin, Joachim Vincent Rupprecht, Julia Vek, Vera Binder, Tim Flaadt, Patrick Schlegel, Semjon Willier, Melanie Gansel, Michaela Döring, Peter Lang, Rupert Handgretinger, Tobias Feuchtinger
Publikováno v:
Drug Design, Development and Therapy. 14:3915-3927
Background High-dose myeloablative conditioning prior to autologous hematopoietic stem cell transplantation (autoHSCT) in pediatric patients is usually highly emetogenic. The antiemetic neurokinin-1 receptor antagonist fosaprepitant was safe and effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7290d342ae62662093f88a168de9e08e
https://doi.org/10.2147/dddt.s260887
https://doi.org/10.2147/dddt.s260887
Autor:
Julia Vek, Rupert Handgretinger, Sebastian Michaelis, Tim Flaadt, Peter Lang, Joachim Vincent Rupprecht, Patrick Schlegel, Michaela Döring, Simone Weber, Karin Melanie Cabanillas Stanchi
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Background Chemotherapy-induced nausea and vomiting (CINV) is a severe and distressing complication during allogeneic hematopoietic stem cell transplantation (alloHSCT). The antiemetic fosaprepitant has shown favorable results in pediatric and adult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b9084691aec9257ddde721a9be1c315
https://doi.org/10.1007/s00432-020-03143-8
https://doi.org/10.1007/s00432-020-03143-8
Autor:
Tim, Flaadt, Lauriane, Lemelle, Virgone, Calogero, Tal, Ben-Ami, Denis, Kachanov, Ulrich, Lauer, Dominik, Schneider, Andrea, Ferrari, Bisogno, Gianni, Yves, Reguerre, Ines, Brecht, Daniel, Orbach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3657::4c1cd7c5a6ea018b86b718397555ac27
http://hdl.handle.net/11577/3458018
http://hdl.handle.net/11577/3458018
Autor:
Abbas Agaimy, Michael Abele, Sarah Voggel, Carl F. Classen, Alexander Claviez, Christian Seitz, Tim Flaadt, Andrea Bier, Uta Dirksen, Ines B. Brecht, Christian Vokuhl, Dominik Schneider
Primary lung carcinomas are very rare paediatric tumours with an incidence of 2/1.000.000 per year. They are clinically and histologically heterogeneous, and there are no therapeutic guidelines for this age group. Therefore, they represent a challeng
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47016c466d5a6e4c299496f0df742af8
https://www.ncbi.nlm.nih.gov/pubmed/34418863
https://www.ncbi.nlm.nih.gov/pubmed/34418863